Early pulmonary arterial hypertension immediately after closure of a ventricular or complete atrioventricular septal defect beyond 6 months of age

被引:3
作者
Heck, P. Bambul [1 ]
Eicken, A. [1 ]
Kasnar-Samprec, J. [2 ]
Ewert, P. [1 ]
Hager, A. [1 ]
机构
[1] Tech Univ Munich, Dept Paediat Cardiol & Congenital Heart Dis, DHM, Lazarett Str 36, D-80290 Munich, Germany
[2] Tech Univ Munich, Dept Cardiovasc Surg, DHM, D-80290 Munich, Germany
关键词
Pulmonary arterial hypertension; VSD; CONGENITAL HEART-DISEASE; EISENMENGER-SYNDROME; SURGICAL CLOSURE; FOLLOW-UP; NITRIC-OXIDE; REPAIR; THERAPY; ADULTS;
D O I
10.1016/j.ijcard.2016.11.056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary arterial hypertension (PAH) is virtually absent after closure of ventricular septal defect (VSD) in the first six months of life. However the prevalence of PAH in patients, who underwent VSD closure later, is not clear. The aim of this study was to analyse the prevalence of PAH after a successful VSD closure after the age of 6 months and whether there are risk factors for developing PAH. Methods: Echocardiographic and right heart catheter data of patients with VSD or complete atrioventricular septal defect, who underwent VSD closure after the age of 6 months in our institution between 01/2005 and 06/2014, were retrospectively analyzed. PAH was defined as mean pulmonary arterial pressure (mPAP) of >= 25 mm Hg or tricuspid regurgitation jet velocity of >= 3.5 m/s. Results: In 228 patients (median age at shunt closure 4.0 years, range 0.5-69) and 174 complete follow-up data (median follow-up 3.7 years, range 0.5-39.4), 9 patients needed pulmonary vasodilator therapy after shunt closure, 4 of them temporarily for up to 79 months. Three patients are still on vasodilator treatment 1, 2.6 and 6 years after surgery, other two were lost to follow-up. Another 6 patients with preoperatively borderline hemo-dynamics due to elevated mPAP and pulmonary vascular resistance, recovered well without signs of postoperative PAH. Conclusion: With the current practice for safe late VSD closure, PAH is very rare at least in the first years of follow-up. In most patients with perioperative PAH, this condition appears to be transient and shows good response on pulmonary vasodilator treatment. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 30 条
[21]   Prevalence of Congenital Heart Defects in Newborns in Germany: Results of the First Registration Year of the PAN Study (July 2006 to June 2007) [J].
Lindinger, A. ;
Schwedler, G. ;
Hense, H. -W. .
KLINISCHE PADIATRIE, 2010, 222 (05) :321-326
[22]   Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease [J].
Lopes, Antonio Augusto ;
O'Leary, Patrick W. .
CARDIOLOGY IN THE YOUNG, 2009, 19 (05) :431-435
[23]   LONG-TERM FOLLOW-UP AFTER SURGICAL CLOSURE OF VENTRICULAR SEPTAL-DEFECT IN INFANCY AND CHILDHOOD [J].
MEIJBOOM, F ;
SZATMARI, A ;
UTENS, E ;
DECKERS, JW ;
ROELANDT, JRTC ;
BOS, E ;
HESS, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (05) :1358-1364
[24]   Long-term follow-up and quality of life after closure of ventricular septal defect in adults [J].
Raap, Goris Bol ;
Meijboom, Folkert J. ;
Kappetein, A. Pieter ;
Galema, Tjebbe W. ;
Yap, Singh-Chien ;
Bogers, Ad J. J. C. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (02) :215-219
[25]   Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years [J].
Roos-Hesselink, JW ;
Meijboom, FJ ;
Spitaels, SEC ;
van Domburg, R ;
van Rijen, EHM ;
Utens, EMWJ ;
Bogers, AJJC ;
Simoons, ML .
EUROPEAN HEART JOURNAL, 2004, 25 (12) :1057-1062
[26]   Hydrogen-Rich Saline Promotes Survival of Retinal Ganglion Cells in a Rat Model of Optic Nerve Crush [J].
Sun, Jing-chuan ;
Xu, Tao ;
Zuo, Qiao ;
Wang, Ruo-bing ;
Qi, Ai-qing ;
Cao, Wen-luo ;
Sun, Ai-jun ;
Sun, Xue-jun ;
Xu, Jiajun .
PLOS ONE, 2014, 9 (06)
[27]   Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension: Hemodynamic outcomes [J].
Talwar, Sachin ;
Keshri, Vikas Kumar ;
Choudhary, Shiv Kumar ;
Gupta, Saurabh Kumar ;
Ramakrishnan, Sivasubramanian ;
Saxena, Anita ;
Kothari, Shyam Sunder ;
Juneja, Rajnish ;
Kumar, Guresh ;
Airan, Balram .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (06) :2570-2575
[28]   Oral sildenafil reduces pulmonary hypertension after cardiac surgery [J].
Trachte, AL ;
Lobato, EB ;
Urdaneta, F ;
Hess, PJ ;
Klodell, CT ;
Martin, TD ;
Staples, ED ;
Beaver, TM .
ANNALS OF THORACIC SURGERY, 2005, 79 (01) :194-197
[29]   Pediatric Pulmonary Hypertension in the Netherlands Epidemiology and Characterization During the Period 1991 to 2005 [J].
van Loon, Rosa Laura E. ;
Roofthooft, Marcus T. R. ;
Hillege, Hans L. ;
ten Harkel, Arend D. J. ;
van Osch-Gevers, Magdalena ;
Delhaas, Tammo ;
Kapusta, Livia ;
Strengers, Jan L. M. ;
Rammeloo, Lukas ;
Clur, Sally-Ann B. ;
Mulder, Barbara J. M. ;
Berger, Rolf M. F. .
CIRCULATION, 2011, 124 (16) :1755-U136
[30]  
Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1161/CIRCULATIONAHA.108.190690]